Furthermore, the retrospective analysis of pathological findings from pancreatic ductal adenocarcinoma patients showed a correlation between the intensity of CEA immunostaining and tumor heterogeneity. The gene discussed is CEACAM5; the disease is pancreatic ductal adenocarcinoma.